169 related articles for article (PubMed ID: 25337195)
1. Correlation of ANXA1 expression with drug resistance and relapse in bladder cancer.
Yu S; Meng Q; Hu H; Zhang M
Int J Clin Exp Pathol; 2014; 7(9):5538-48. PubMed ID: 25337195
[TBL] [Abstract][Full Text] [Related]
2. Identification of proteins differentially expressed in adriamycin-resistant (pumc-91/ADM) and parental (pumc-91) human bladder cancer cell lines by proteome analysis.
Meng Q; Lei T; Zhang M; Zhao J; Zhao XH; Zhang M
J Cancer Res Clin Oncol; 2013 Mar; 139(3):509-19. PubMed ID: 23183654
[TBL] [Abstract][Full Text] [Related]
3. Expression of Annexin A2 and Its Correlation With Drug Resistance and Recurrence of Bladder Cancer.
Hu H; Zhao J; Zhang M
Technol Cancer Res Treat; 2016 Dec; 15(6):NP61-NP68. PubMed ID: 26637476
[TBL] [Abstract][Full Text] [Related]
4. [Expression of Annexin A1 in paclitaxel-resistant ovarian carcinoma and its clinical significance].
Zou L; Cao L; Yi H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Aug; 39(8):784-9. PubMed ID: 25202946
[TBL] [Abstract][Full Text] [Related]
5. The Reversal Effect and Its Mechanisms of Tetramethylpyrazine on Multidrug Resistance in Human Bladder Cancer.
Wang S; Lei T; Zhang M
PLoS One; 2016; 11(7):e0157759. PubMed ID: 27391608
[TBL] [Abstract][Full Text] [Related]
6. Nucleophosmin1 associated with drug resistance and recurrence of bladder cancer.
Hu H; Meng Q; Lei T; Zhang M
Clin Exp Med; 2015 Aug; 15(3):361-9. PubMed ID: 24925635
[TBL] [Abstract][Full Text] [Related]
7. Annexin A1 is involved in the acquisition and maintenance of a stem cell-like/aggressive phenotype in prostate cancer cells with acquired resistance to zoledronic acid.
Bizzarro V; Belvedere R; Milone MR; Pucci B; Lombardi R; Bruzzese F; Popolo A; Parente L; Budillon A; Petrella A
Oncotarget; 2015 Sep; 6(28):25076-92. PubMed ID: 26312765
[TBL] [Abstract][Full Text] [Related]
8. Annexin A1: A new immunohistological marker of cholangiocarcinoma.
Hongsrichan N; Rucksaken R; Chamgramol Y; Pinlaor P; Techasen A; Yongvanit P; Khuntikeo N; Pairojkul C; Pinlaor S
World J Gastroenterol; 2013 Apr; 19(16):2456-65. PubMed ID: 23674846
[TBL] [Abstract][Full Text] [Related]
9. Annexin-I overexpression is associated with tumour progression and independently predicts inferior disease-specific and metastasis-free survival in urinary bladder urothelial carcinoma.
Li CF; Shen KH; Huang LC; Huang HY; Wang YH; Wu TF
Pathology; 2010 Jan; 42(1):43-9. PubMed ID: 20025479
[TBL] [Abstract][Full Text] [Related]
10. STAT3 signaling pathway in drug-resistant bladder cancer cell line.
Lei T; Zhou S; Meng Q; Zhang M
J Biol Regul Homeost Agents; 2019; 33(5):1347-1357. PubMed ID: 31912690
[TBL] [Abstract][Full Text] [Related]
11. Annexin A1 is involved in resistance to 5-FU in colon cancer cells.
Onozawa H; Saito M; Saito K; Kanke Y; Watanabe Y; Hayase S; Sakamoto W; Ishigame T; Momma T; Ohki S; Takenoshita S
Oncol Rep; 2017 Jan; 37(1):235-240. PubMed ID: 27840982
[TBL] [Abstract][Full Text] [Related]
12. Annexin A1 Expression Is Associated with Epithelial-Mesenchymal Transition (EMT), Cell Proliferation, Prognosis, and Drug Response in Pancreatic Cancer.
Oshi M; Tokumaru Y; Mukhopadhyay S; Yan L; Matsuyama R; Endo I; Takabe K
Cells; 2021 Mar; 10(3):. PubMed ID: 33804148
[TBL] [Abstract][Full Text] [Related]
13. Exosomal ANXA1 derived from thyroid cancer cells is associated with malignant transformation of human thyroid follicular epithelial cells by promoting cell proliferation.
Li Q; Liu W; Wang Z; Wang C; Ai Z
Int J Oncol; 2021 Dec; 59(6):. PubMed ID: 34779491
[TBL] [Abstract][Full Text] [Related]
14. Annexin A1 down-regulation in head and neck cancer is associated with epithelial differentiation status.
Garcia Pedrero JM; Fernandez MP; Morgan RO; Herrero Zapatero A; Gonzalez MV; Suarez Nieto C; Rodrigo JP
Am J Pathol; 2004 Jan; 164(1):73-9. PubMed ID: 14695321
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of annexin A1 predicts poor prognosis in human hepatocellular carcinoma and enhances cell malignant phenotype.
Lin Y; Lin G; Fang W; Zhu H; Chu K
Med Oncol; 2014 Dec; 31(12):327. PubMed ID: 25412936
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of multidrug resistance‑related proteins in adriamycin‑resistant (pumc‑91/ADM) and parental (pumc‑91) human bladder cancer cell lines.
Zhao M; Yu S; Zhang M
Mol Med Rep; 2016 Nov; 14(5):4741-4746. PubMed ID: 27748815
[TBL] [Abstract][Full Text] [Related]
17. Annexin-A1 - A Blessing or a Curse in Cancer?
Foo SL; Yap G; Cui J; Lim LHK
Trends Mol Med; 2019 Apr; 25(4):315-327. PubMed ID: 30871809
[TBL] [Abstract][Full Text] [Related]
18. Identification of Annexin A1 protein expression in human gastric adenocarcinoma using proteomics and tissue microarray.
Zhang ZQ; Li XJ; Liu GT; Xia Y; Zhang XY; Wen H
World J Gastroenterol; 2013 Nov; 19(43):7795-803. PubMed ID: 24282368
[TBL] [Abstract][Full Text] [Related]
19. Role of Annexin A1 in Squamous Cell Lung Cancer Progression.
Elakad O; Li Y; Gieser N; Yao S; Küffer S; Hinterthaner M; Danner BC; von Hammerstein-Equord A; Ströbel P; Bohnenberger H
Dis Markers; 2021; 2021():5520832. PubMed ID: 33959206
[TBL] [Abstract][Full Text] [Related]
20. Identification of ANXA1 as a lymphatic metastasis and poor prognostic factor in pancreatic ductal adenocarcinoma.
Liu QH; Shi ML; Bai J; Zheng JN
Asian Pac J Cancer Prev; 2015; 16(7):2719-24. PubMed ID: 25854353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
